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A B S T R A C T
Aging pediatric cranioplasty patients with titanium implants are a population at risk for scalp breakdown and
implant extrusion. Complications from titanium use in adult cranioplasty patients are well documented in the
medical literature. Reports of complications focused on pediatric populations are sparse. In this case series, we
report two examples of negative sequelae associated with titanium utilization in infant cranioplasty and discuss
our treatment strategy for each case.
1. Introduction
Cranioplasty is the surgical re-contouring of the cranium.
Indications for cranioplasty include congenital defects and traumatic
injury. Autologous bone is the preferred medium for the reconstruction
of large calvarial defects; alternatively, biomaterials are an option [1].
Patient age, limited donor site availability, defect size, history of bone
graft resorption and/or site infection influence whether autologous
bone or biomaterials are used [1]. When biomaterials are elected, ti-
tanium is a frequently used alloplastic material in adult cranioplasty
[1–3].
Complications from titanium use in adult patients undergoing cra-
nioplasty are well documented in the medical literature, the most se-
vere of which necessitate explantation of hardware [4–6]. While the
literature on the long-term outcomes in the pediatric population is
sparse; authors do suggest that titanium is safe for use in pediatric and
infant cranioplasty [7]. In this series, we report two cases of negative
sequelae associated with titanium-based cranioplasty performed in in-
fancy. Treatment strategies for each case are described. Each case
presented with device extrusion necessitating hardware explantation.
2. Cases
2.1. Case 1
Patient 1 is a five-year-old male who presented with complaints of
headaches and tenderness over several areas of the skull. Past history
was significant for bilateral coronal craniosynostosis and anterior
cranial vault remodeling in infancy. Postoperatively, the patient de-
veloped a wound infection that resulted in loss of the bone flap, which
gave rise to a large right frontoparietal skull defect. This defect was
covered with titanium mesh.
On examination, the hardware was palpable beneath the sites of
reported tenderness. Computed tomography (CT) of the head revealed
titanium mesh (Fig. 1) with very thin scalp over its margins consistent
with those areas of tenderness clinically. As he demonstrated no diploe
on CT, a split calvarial graft was not an option for reconstruction. It was
therefore decided to use a patient specific polyether ether ketone
(PEEK) implant to obtain skull continuity after explantation of the ti-
tanium mesh. Via the previous bicoronal incision, the titanium hard-
ware was explanted (Fig. 2) and the defect was filled with the custom
PEEK implant (Fig. 3). He recovered without incident. He is two years
post procedure and has since done well with resolution of headaches
and scalp tenderness.
2.2. Case 2
Patient 2 is a 23-year-old male with a past medical history sig-
nificant for hypothalamic pilocytic astrocytoma diagnosed at age 15.
The tumor was initially excised via a frontal craniotomy. He recovered
but suffered significant neurologic impairment post-procedure. His
postoperative course was complicated by frontal bone loss with a re-
sultant anterior calvarial defect that was covered by titanium mesh. He
received a six-week regimen of radiotherapy, resulting in remission. At
age 17, the tumor recurred, and aggressive chemotherapy was initiated.
Imaging revealed cavitation and cyst formation within the mass, and he
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Fig. 1. Patient 1–3 dimensional CT scan reconstruction
demonstrating titanium implant coverage.
Fig. 2. Patient 1- Right frontoparietal skull defect covered
with layers of titanium mesh.
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Fig. 3. Patient 1- Calvarial continuity reestablished with a
patient specific polyetheretherketone (PEEK) construct.
Fig. 4. Patient 2–3 dimensional CT scan reconstruction
demonstrating titanium implant coverage.
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was treated with image-guided left frontal craniotomy and micro-
surgical excision of the mass. He recovered and was disease-free for five
years.
At age 23, he presented with new erythema and tenderness over the
right frontal skull and forehead. On exam, he had evidence of extrusion
of the anterior margin of the titanium mesh with a local cellulitis. CT
scan of the head confirmed these findings (Fig. 4). Due to his significant
neurologic challenges and his difficult to control self-deprecating be-
haviors, the family initially refused extensive intervention that would
have included explantation of his titanium mesh, resulting in a large
anterior defect. As such, a staged approach was offered that included
initial local control with ultimate reconstruction in a second procedure.
The presenting extrusion and cellulitis were targeted via local excision
of the extruded margin of mesh and a two-week course of anti-
microbials which effectively treated the local process.
Three months following the resolution of the cellulitis, he re-pre-
sented with the margin of the titanium extruding again. No obvious
cellulitis was evident. As the family again declined a split calvarial
graft, and because the soft tissues were not intact, it was decided that
the plan would be to trial a cadaveric bone source en lieu of an allo-
plastic material after removal of all titanium. As such, cadaveric split
thickness rib bone grafts were fashioned for temporary continuity and
interface over the brain (Fig. 5). It was recognized that long term en-
graftment of the allografts would likely fail. The intent being to treat
any infectious process in preparation for a prosthetic implant. Indeed,
he recovered without incident post titanium explantation and rib
grafting, completed a course of antimicrobials, and remained with a
solid construct for 6months until the family noted a soft region evol-
ving. CT confirmed resorption of the rib grafts. With no evidence of any
inflammatory process, a patient specific PEEK construct was fashioned
and placed in a final procedure to reestablished continuity of the cal-
varium. The patient did well postoperatively with no further scalp or
skull concerns. He was symptom free for 12months at which time the
tumor recurred. His parents decided that supportive care would be the
way forward and he succumbed to his primary disease 14months later.
3. Discussion
Titanium hardware exhibits high biocompatibility, low levels of
both corrosion and toxicity and an established safety profile in the adult
cranioplasty population [1–3,8,9]. In the pediatric population, titanium
implants may not be tolerated as well. The distensibility of a thinner
scalp and pressure injury in children with limited mobility secondary to
neurodevelopment delay may complicate its use [10]. The presence of
titanium beneath the soft tissues of the scalp may result in tissue injury
recognized in patients as pain, redness, swelling, and ultimately ex-
trusion of the hardware [4,6]. Once exposed to extrinsic microorgan-
isms there is potential for local cellulitis and central nervous system
Fig. 5. Patient 2- Placement of cadaveric split-rib graft for
calvarial continuity.
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infection [6]. Treatment strategies for these patients can be challen-
ging, as there is significant variability between patients at presentation.
Functional status and ethical issues must be considered prior to re-
legating a patient and family to an extensive intra and postoperative
course that may itself be fraught with obstacles. As such, an in-
dividualized approach merits discussion with families.
In the case of titanium extrusion with no underlying defect, hard-
ware removal is the definitive treatment. The patient, who presents
with imminent extrusion over a calvarial defect amenable to re-
construction, benefits from preemptive intervention prior to extrusion.
Size of the defect, presence of a diploe, patient age, and neurodeve-
lopmental status, are considerations before intervention. Autologous
split-thickness calvarial graft is preferable if sufficient donor stock is
present. Allograft and alloplastic alternatives are also viable options.
The patient who presents with titanium extrusion, acute cellulitis, and a
calvarial defect amenable to reconstruction can be managed with
staged intervention. First, explantation of the offending hardware, local
debridement and targeted antibiotic therapy sterilizes the field. While
compliant patients may use helmets to protect the exposed brain be-
neath large calvarial defects, alloplastic bone graft for temporary cov-
erage is an option for patients who cannot be compliant with helmet
use.
4. Conclusion
Cranioplasty patients with titanium placed at infancy are a popu-
lation at risk for scalp breakdown and implant extrusion. These two
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